These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8289091)

  • 1. Staurosporine differentially inhibits glioma versus non-glioma cell lines.
    Baltuch GH; Dooley NP; Couldwell WT; Yong VW
    J Neurooncol; 1993 May; 16(2):141-7. PubMed ID: 8289091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
    Baltuch GH; Couldwell WT; Villemure JG; Yong VW
    Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway.
    Baltuch GH; Yong VW
    Brain Res; 1996 Feb; 710(1-2):143-9. PubMed ID: 8963653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
    Couldwell WT; Uhm JH; Antel JP; Yong VW
    Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
    Couldwell WT; Hinton DR; He S; Chen TC; Sebat I; Weiss MH; Law RE
    FEBS Lett; 1994 May; 345(1):43-6. PubMed ID: 8194597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
    Couldwell WT; Antel JP; Yong VW
    Neurosurgery; 1992 Oct; 31(4):717-24; discussion 724. PubMed ID: 1407458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
    Pollack IF; Kawecki S; Lazo JS
    J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.
    Pollack IF; Kawecki S
    J Neurooncol; 1997 Feb; 31(3):255-66. PubMed ID: 9049854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
    Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
    J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C; Budworth J; Gescher A
    Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine.
    Schwartz GK; Redwood SM; Ohnuma T; Holland JF; Droller MJ; Liu BC
    J Natl Cancer Inst; 1990 Nov; 82(22):1753-6. PubMed ID: 2231770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    J Neurosurg; 1990 Jul; 73(1):98-105. PubMed ID: 2161913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity.
    Meyer T; Regenass U; Fabbro D; Alteri E; Rösel J; Müller M; Caravatti G; Matter A
    Int J Cancer; 1989 May; 43(5):851-6. PubMed ID: 2714889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
    Schwartz GK; Jiang J; Kelsen D; Albino AP
    J Natl Cancer Inst; 1993 Mar; 85(5):402-7. PubMed ID: 8433394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.
    Baltuch GH; Dooley NP; Rostworowski KM; Villemure JG; Yong VW
    J Neurooncol; 1995; 24(3):241-50. PubMed ID: 7595754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
    Kraiem Z; Sadeh O; Yosef M; Aharon A
    Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system.
    Couldwell WT; Antel JP; Apuzzo ML; Yong VW
    J Neurosurg; 1990 Oct; 73(4):594-600. PubMed ID: 2398390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of human and mouse astrocytes in vitro: signalling through the protein kinase C pathway.
    Yong VW
    J Neurol Sci; 1992 Aug; 111(1):92-103. PubMed ID: 1403003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells.
    Sharif TR; Sharif M
    Int J Oncol; 1999 Feb; 14(2):327-35. PubMed ID: 9917510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.